Are Transfusions a Barrier to High-Quality End-of-Life Care in Hematology?
Dr. LeBlanc and Dr. Litzow take a look at an issue within the field consisting of hematologists referring their patients to hospice late or not at all even when there are s
Venous Thrombosis on One Side and Bleeding on the Other: How to Walk the Fence in Cancer Patients With Thrombosis and Thrombocytopenia
Dr. Linkins provides guidance on how to manage recurrent thrombosis and bleeding in a cancer patient with severe thrombocytopenia that develops VTE.
Dr. Kendra Sweet discusses tyrosine kinase inhibitor cessation as a treatment option for chronic phase chronic myeloid leukemia.
Dr. DeBaun discusses a study that presents strong evidence that sickle cell trait is not associated with ischemic stroke.
Drs. Leidy Isenalumhe and Alex Boucher have a conversation about what to expect at the inaugural ASH-a-Palooza.
July/August 2018Volume 15, Issue 4
View all Features articles
View all Diffusion articles
Dr. Thompson covers ASH advocacy efforts that support the Society's global mission.
View all president's column articles
View all Ask the Hematologist articles
View all Clinical Trials Corner articles
View all Mini Review articles
CMS released a National Coverage Determination entitled Next Generation Sequencing for Medicare Beneficiaries with Advanced Cancer. ASH submitted comments on the proposal along with over 300 other groups, including physician specialty societies, patient advocacy groups, and industry groups.
Senators Tim Scott (R-SC) and Cory Booker (D-NJ) introduced the Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018.
On December 20, the House of Representatives and the Senate voted to approve H.R. 1, tax reform legislation. Select members of each chamber came together to resolve disagreements between the two versions passed by the House and Senate.
Congress spent much of 2017 focused on the repeal and replace of the Affordable Care Act (ACA). Included is a summary of Congress and the Administration’s actions on repeal and replace of the ACA that occurred in 2017.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology